Pestano Gary Anthony 4

What Happened
Gary Anthony Pestano, Chief Development Officer of Biodesix, had restricted stock units (RSUs) convert into 1,481 shares on Feb 9, 2026 (reported Feb 11). Of those vested/converted shares, 540 were sold in the open market on Feb 10 at a weighted average price of $10.08 for proceeds of $5,445 to cover taxes. The filing also shows 68 and 1,413-share conversion/disposition line items at $0.00, which reflect the RSU-to-share conversion/withholding mechanics rather than separate cash sales.

Key Details

• Transaction dates: RSU conversion/exercise on 2026-02-09; open-market sale to cover taxes on 2026-02-10. Filing date: 2026-02-11 (timely).
• Shares involved: 1,481 shares converted (derivative exercise/conversion); 540 shares sold in market for $10.08 weighted avg ($5,445 total).
• Price notes: Shares sold to cover taxes executed at prices ranging $9.94–$10.21; $10.08 is the weighted average reported for Pestano’s portion (see footnote offering breakdown on request).
• Footnotes of interest:
  • RSUs represent contingent rights to receive one share each (F1).
  • Some shares were sold automatically to cover tax withholding upon RSU vesting (F2, F3).
  • Vesting schedules noted: a series of quarterly and annual installments starting Feb 8, 2022 and Feb 8, 2023 respectively (F4, F6).
  • Share counts adjusted for a 1-for-20 reverse split effective Sep 15, 2025 (F5).
• Shares owned after the transaction: not specified in the provided transaction summary.

Context

• This was not a discretionary "sale" signaling a change in investment view but a routine tax-withholding sale tied to RSU vesting (cashless/automatic sale for taxes). For derivative entries (code M), the filing reflects conversion/exercise of RSUs into actual shares; the $0.00 line items indicate conversion/transfer steps rather than market sales.
• Filing appears timely (filed two days after the principal conversion date).